Cadent Capital Advisors LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 23.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 702 shares of the healthcare conglomerate’s stock after selling 220 shares during the period. Cadent Capital Advisors LLC’s holdings in UnitedHealth Group were worth $355,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Quarry LP boosted its holdings in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on UNH shares. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, December 9th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $626.79.
UnitedHealth Group Price Performance
Shares of NYSE:UNH traded up $23.07 during trading on Monday, reaching $543.76. 3,922,638 shares of the company traded hands, compared to its average volume of 4,149,262. The company’s 50 day moving average is $555.25 and its two-hundred day moving average is $562.50. The firm has a market capitalization of $500.41 billion, a PE ratio of 35.42, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the firm earned $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Best Aerospace Stocks Investing
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is a Bond Market Holiday? How to Invest and Trade
- Delta Can Fly to New Highs in 2025; Here’s Why
- What Are Trending Stocks? Trending Stocks Explained
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.